First Alzheimer's drug to slow disease progression gets full FDA approval, likely triggering broader Medicare coverage - WSVN 7News | Miami News, Weather, Sports

(CNN) — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course<a class="excerpt-read-more" href="https://wsvn.com/news/us-world/first-alzheimers-drug-to-slow-disease-progression-gets-full-fda-approval-likely-triggering-broader-medicare-coverage/">Read More</a>

Related Keywords

United States ,Florida ,Americans ,Georges Naasan ,Lawrence Honig ,Joe Montminy ,Ivan Cheung ,Teresa Buracchio ,Centers For Medicare ,Office Of Neuroscience ,Columbia University Irving Medical Center ,Division Of Behavioral Neurology ,Medicaid Services ,Drug Administration On ,Cnn ,Kaiser Family Foundation ,Drug Administration ,Drug Evaluation ,Behavioral Neurology ,Sue Rottura ,Vivo Infusion ,Kaiser Family ,